Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Irwin

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Plos One|May 25, 2023
RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limbAnanyaa Sridhar, Dawood Khan, Jessie A Elliott, et al.
The Journal of Endocrinology|August 31, 2023
Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP miceNeil Tanday, Aimee Coulter-Parkhill, R Charlotte Moffett, et al.
Biochemical Pharmacology|June 16, 2009
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic propertiesBarry D Kerr, Nigel Irwin, Finbarr P M O'Harte, et al.
European Journal of Pharmacology|September 2, 2006
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1Brian D Green, Nigel Irwin, Nicola A Duffy, et al.
The Journal of Endocrinology|August 25, 2022
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed miceRyan A Lafferty, Laura M McShane, Zara J Franklin, et al.
Regulatory Peptides|May 6, 2006
Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16)Nigel Irwin, Brian D Green, Jeremy C Parker, et al.
Bone|December 11, 2012
Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in miceChristine Gaudin-Audrain, Nigel Irwin, Sity Mansur, et al.
Diabetes/Metabolism Research and Reviews|December 1, 2018
Exendin-4(Lys<sup>27</sup> PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) miceAnnie Hasib, Ming T Ng, Neil Tanday, et al.
Frontiers in Endocrinology|March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic MiceRyan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Biochimie|April 19, 2022
Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed miceZara J Franklin, Ryan A Lafferty, Peter R Flatt, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Plos One|May 25, 2023
RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limbAnanyaa Sridhar, Dawood Khan, Jessie A Elliott, et al.
The Journal of Endocrinology|August 31, 2023
Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP miceNeil Tanday, Aimee Coulter-Parkhill, R Charlotte Moffett, et al.
Biochemical Pharmacology|June 16, 2009
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic propertiesBarry D Kerr, Nigel Irwin, Finbarr P M O'Harte, et al.
European Journal of Pharmacology|September 2, 2006
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1Brian D Green, Nigel Irwin, Nicola A Duffy, et al.
The Journal of Endocrinology|August 25, 2022
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed miceRyan A Lafferty, Laura M McShane, Zara J Franklin, et al.
Regulatory Peptides|May 6, 2006
Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16)Nigel Irwin, Brian D Green, Jeremy C Parker, et al.
Bone|December 11, 2012
Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in miceChristine Gaudin-Audrain, Nigel Irwin, Sity Mansur, et al.
Diabetes/Metabolism Research and Reviews|December 1, 2018
Exendin-4(Lys<sup>27</sup> PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) miceAnnie Hasib, Ming T Ng, Neil Tanday, et al.
Frontiers in Endocrinology|March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic MiceRyan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Biochimie|April 19, 2022
Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed miceZara J Franklin, Ryan A Lafferty, Peter R Flatt, et al.
Pageof 17